The Neurotech Now panel at DeviceTalks West 2025 will feature leaders from Synchron, Cognito Therapeutics and Subsense.

Looking further back, Cognito's Breakthrough Device Designation was preceded by neurodegenerative digital therapeutics company Dthera Sciences, which gained the designation in 2018. Alzheimer's and ...

Alzheimer’s disease research at MIT spawned Cognito Therapeutics, a startup whose medical device uses light and sound to modulate electrical activity that supports brain health. The company’s ...

Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer's By Andrea Park Mar 22, 2023 8:00am Cognito Therapeutics Alzheimer's disease neuromodulation neurostimulation ...